Radionetics Oncology, Inc. — Form D

Radionetics Oncology, Inc. of MENLO PARK, CA, a company, filed a Form D exempt-offering notice with the SEC on 2023-08-15. The offering totals $68.7M, of which $54.2M was reported sold. Industry: Pharmaceuticals.

Offering

• Filed: 2023-08-15
• Form: D
• Accession: 0001989304-23-000001
• Industry: Pharmaceuticals
• Exemptions: 06b
• Total offering: $68.7M
• Amount sold: $54.2M
• Remaining: $14.5M
• Investors: 6
• Date of first sale: 2023-08-01
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-489773

Issuer

• Name: Radionetics Oncology, Inc.
• CIK: 0001989304
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2021
• Address: 70 WILLOW STREET, MENLO PARK, CA, 94025
• Phone: 858-218-6617

Officers, directors & promoters (9)

More

• CIK 1989304 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search